Tesamorelin is a stabilized analogue of growth hormone-releasing hormone (GHRH), engineered to increase resistance to enzymatic degradation and enhance GH release. It has been widely studied in metabolic syndrome, HIV-associated lipodystrophy, and aging-related GH decline models.
Research applications include:
-
Promoting GH secretion and stimulating IGF-1 production in GH-deficient states.
-
Reducing visceral adipose tissue, particularly in studies of metabolic syndrome and fat redistribution.
-
Supporting lipid metabolism regulation, with observed improvements in triglyceride and cholesterol profiles.
-
Studying cognitive benefits of GH elevation, especially in aging models.
Tesamorelin offers targeted endocrine modulation with minimal off-target hormonal effects.
Reconstitution Instructions:
Reconstitute with BAC water. Refrigerate after reconstitution and use under sterile research conditions. Use our Peptide Calculator
For research purposes only. Not for human consumption.
Reviews
There are no reviews yet.